Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why
We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where ...
Tal Zaks's Israeli startup targets rare genetic diseases
"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...
STAT11h
Vertex, U.K. reach reimbursement deal for CRISPR-based medicine for sickle cell disease
People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...
STAT8d
RFK Jr. invested in gene-editing biotech, is owed millions for book advances, disclosures show
It's the clearest view yet of RFK Jr.'s investments and potential conflicts of interest as he works to become HHS secretary.
From Underperformance To Opportunity: Biotech's Case For 2025
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
MIT Technology Review1d
The Download: mice with two dads, and Meta’s fact-checking challenges
Once a week, Sun Kai has a video call with his mother, and they discuss his day-to-day life. But Sun’s mother died five years ...
Escaping the endosome: BEND lipids improve LNP mRNA delivery and gene editing
Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...
PBS28d
5 years after it appeared, things we know and still don’t know about COVID
But this theory has not been proven for the virus that causes COVID-19. Wuhan is home to several research labs involved in collecting and studying coronaviruses, fueling debate over whether the ...